Job opportunities

Research Assistant


Region Hovedstaden




Research and Development

Application deadline

28 March 2018


We are looking for a highly motivated research assistant to join the discovery of new innovative treatments for brain disorders. The Department of Molecular Screening is responsible for molecular pharmacology and screening support for Lundbeck’s drug discovery projects. Techniques represented in the Department include molecular pharmacology, electrophysiology and various cell-based and biochemical assays to profile small molecules and biologics. The Department currently consists of 8 academics, 5 technicians and 2 students and is based at Lundbeck’s headquarters in Valby, Copenhagen. 

Your job and key responsibilities
You will be part of a team providing molecular pharmacology and screening support for research projects aiming for new drug candidates for psychiatric and neurological diseases. You will be responsible for planning and executing studies and reporting these to project teams. A significant part of the work will be based in the lab generating and analyzing pharmacology data to support assay development and hit finding as well as the understanding of new drug candidates’ structure-activity relationship and mechanism of action at the molecular target. Much of the lab work will be based on advanced instrumentation and robotics for automatization. You will work closely together with technicians and academics in the department and also will be involved in cross-functional project teams as well as in CRO interactions.

We offer
The opportunity to join a team of highly qualified colleagues working in an open atmosphere with excellent development possibilities. Lundbeck is a global pharmaceutical company with approximately 5,000 employees in 55 countries specialized in psychiatric and neurological disorders. The key focus areas are depression, schizophrenia, Parkinson's disease and Alzheimer's disease.

Our preferred candidate has the following personal and professional qualifications:

  • Master’s degree in molecular pharmacology, biochemistry, molecular cell biology or related area.
  • Excellent receptor pharmacology understanding and high scientific standards.
  • Experience with drug discovery an advantage.
  • Genuine interest in laboratory work.
  • Hands on experience handling advanced instrumentation and robotics required.
  • Efficient and goal oriented work style with flexible mind-set.
  • Team player with strong collaboration and communication skills.
  • Fluent in oral and written English.

Further information
Please contact Head of Department, Molecular Screening, Lars Christian Biilmann Rønn We also recommend that you have a look at our website.

Your application
Please click on the link below to apply for the job. Your application and CV should not be sent via email. Applications must be received no later than March 28, 2018.

Apply for the job here

Please apply for this job from a desktop/laptop computer.

Lundbeck is a global pharmaceutical company specialized in psychiatric and neurological disorders. For more than 70 years, we have been at the forefront of research within neuroscience. Our key areas of focus are depression, schizophrenia, Parkinson's disease and Alzheimer's disease.

An estimated 700 million people worldwide are living with psychiatric and neurological disorders and far too many suffer due to inadequate treatment, discrimination, a reduced number of working days, early retirement and other unnecessary consequences. Every day, we strive for improved treatment and a better life for people living with psychiatric and neurological disorders – we call this Progress in Mind.


Our approximately 5,300 employees in 55 countries are engaged in the entire value chain throughout research, development, production, marketing and sales. Our pipeline consists of several late-stage development programmes and our products are available in more than 100 countries. We have research centres in China and Denmark and production facilities in China, Denmark, France and Italy. Lundbeck generated revenue of DKK 14.6 billion in 2015 (EUR 2 billion; USD 2.2 billion).

For additional information, we encourage you to visit our corporate site and connect with us on Twitter at @Lundbeck .


Corporate film

Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders.

Follow us on LinkedIn

Linked-in image

Become part of Lundbeck's professional network to stay up-to-date with our worldwide career opportunities.

Go to LinkedIn

Follow us on Twitter

Stay updated with the latest news and conversations around Lundbeck and our business. 

Go to Twitter

Visit us on YouTube

Learn about our disease areas and hear stories by patients living with psychiatric and neurological disorders. 

Go to YouTube
Cookie Policy
You have chosen to leave Lundbeck does not have any responsibility for the content provided by other websites. Click "OK" to continue or "Cancel" to remain on